DFTX
Definium Therapeutics, Inc.
NASDAQ: DFTX · HEALTHCARE · BIOTECHNOLOGY
$21.40
-2.95% today
Updated 2026-05-11
Market cap
$2.40B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.50
Dividend yield
—
52W range
$6 – $26
Volume
1.9M
Definium Therapeutics, Inc. (DFTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-64.10%
ROA
-28.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | — | $-92656.00 | — | — | — |
| 2016 | — | $-179900.00 | — | — | — |
| 2017 | — | $-1.23M | — | — | — |
| 2018 | — | $-857944.00 | — | — | — |
| 2019 | — | $-1.12M | — | — | — |
| 2020 | — | $-34.10M | — | — | — |
| 2021 | $0.00 | $-93.04M | — | — | — |
| 2022 | $0.00 | $-56.80M | — | — | — |
| 2023 | $0.00 | $-95.73M | — | — | — |
| 2024 | $0.00 | $-108.68M | — | — | — |
| 2025 | $0.00 | $-183.79M | — | — | — |